Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema.

Anadi KhatriPratap KarkiSagun Narayan JoshiRanju Kharel Sitaula

Published in: BMJ open ophthalmology (2017)

Patients with bilateral DME treated with bevacizumab in one eye produced a bilateral response. Eyes with greater CSMT due to DME elicited higher levels of response in the untreated eye.

Keyphrases

optical coherence tomography
diabetic retinopathy
case report
cataract surgery
metastatic colorectal cancer
type diabetes